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Background. Disinhibition and decision-making skills play an important role in theories on the cause and outcome of
addictive behaviors such as substance use disorders and pathological gambling. In recent studies, both disinhibition
and disadvantageous decision-making strategies, as measured by neurocognitive tests, have been found to inﬂuence
the course of substance use disorders. Research on factors aﬀecting relapse in pathological gambling is scarce.
Method. This study investigated the eﬀect of both self-reported impulsivity and reward sensitivity, and neuro-
cognitively assessed disinhibition and decision-making under conﬂicting contingencies, on relapse in a group of
46 pathological gamblers.
Results. Logistic regression analysis indicated that longer duration of the disorder and neurocognitive indicators
of disinhibition (Stop Signal Reaction Time) and decision-making (Card Playing Task) were signiﬁcant predictors of
relapse (explaining 53% of the variance in relapse), whereas self-reported impulsivity and reward sensitivity did not
signiﬁcantly predict relapse. Overall classiﬁcation accuracy was 76%, with a positive classiﬁcation accuracy of 76%
and a negative classiﬁcation accuracy of 75%.
Conclusions. Duration of the disorder and neurocognitive measures of disinhibition and decision-making are powerful
predictors of relapse in pathological gambling. The results suggest that endophenotypical neurocognitive characteristics
are more promising in the prediction of relapse in pathological gambling than phenotypical personality characteristics.
Neurocognitive predictors may be useful to guide treatment planning of follow-up contacts and booster sessions.
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Introduction
Substance dependence and pathological gambling
(PG) have similarities at the phenotypcial and endo-
phenotypical level (Tamminga & Nestler, 2006). At
the phenotypical level, both PG and substance depen-
dence are disorders characterized by a lack of self-
regulation (Goldstein et al. 2001; Goldstein & Volkow,
2002). Although classiﬁed as an impulse control dis-
order, PG is regarded as a ‘behavioral addiction’ by
some researchers (Marks, 1990 ; Blanco et al. 2001),
and several PG criteria in the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV-TR) resemble
those of substance dependence, such as loss of control,
tolerance, withdrawal, and the experience of negative
consequences due to gambling-related behavior (APA,
1994). Diminished self-regulation is displayed when
an addicted person is not able to inhibit the urge
for a desired drug or behavior, and to shift his or
her behavior from the addictive reinforcement to
a less self-destructive reinforcement. At the endo-
phenotypical level, diminished neurocognitive self-
regulatory functions have been found in substance
dependence and PG (Horner et al. 1999 ; Paraherakis
et al. 2001; Bechara & Damasio, 2002 ; Bolla et al.
2003 ; Goudriaan et al. 2006), and recent neuro-
imaging studies show abnormalities in the brain
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reward circuitry in substance dependence and PG
(Kubota et al. 2001 ; O’Neill et al. 2001 ; Bolla et al. 2003;
Potenza et al. 2003 ; Reuter et al. 2005).
Alcohol and drug dependence are disorders with
a chronic course, and periods of remission are often
followed by relapse (APA, 1994; Hser et al. 2001 ;
Delucchi et al. 2004). Understanding relapse and the
predictors of relapse is of scientiﬁc interest in the
study of the long-term course of addictive behaviors,
and of practical relevance for the planning and evalu-
ation of treatment. Although the DSM-IV-TR charac-
terizes PG as a progressive and chronic disorder,
and relapse is considered an important issue in the
study of PG, research into this topic is scarce
(Blaszczynski et al. 1991 ; National Research Council,
1999 ; Ledgerwood & Petry, 2006).
In substance dependence research, factors aﬀecting
relapse and treatment outcome have been studied
quite extensively. Several studies reported that a
higher severity of dependence was predictive of
relapse (Babor et al. 1987 ; Langenbucher et al. 1996 ;
Simpson et al. 1999 ; but see: Allsop et al. 2000 ;
Bottlender & Soyka, 2005). Higher levels of self-
reported impulsivity are also found to be predictive
of relapse and early treatment drop-out in substance
dependence (Moeller et al. 2001 ; Doran et al. 2004).
Other studies in substance-dependent populations
indicate that deﬁciencies in neurocognitive functions
have a negative eﬀect on the outcome of inter-
ventions such as early drop-out (Teichner et al. 2002 ;
Aharonovich et al. 2003), shorter length of treatment
adherence (Fals-Stewart & Schafer, 1992 ; Fals-Stewart,
1993), smaller beneﬁts of treatment interventions
(Smith & McCrady, 1991 ; Teichner et al. 2001), and
higher relapse rates (Tapert et al. 1999 ; Allsop et al.
2000 ; Bowden-Jones et al. 2005). A recent fMRI study
indicated that relapse in a group of metamphetamine-
dependent patients was associated with less activation
in the dorsolateral prefrontal cortex, temporal cortex,
as well as less activation in the anterior cingulate
cortex, brain areas important for functions such as
inhibitory control and decision-making processes
(Paulus et al. 2005).
Given the ﬁndings in alcohol and drug dependence
relapse studies, this study will focus on impulsivity
and disinhibition as a factor in the relapse of PG. From
a theoretical point of view, the ability to refrain
from gambling, and not to give in to impulses, can be
viewed as a cardinal feature inﬂuencing the course of
PG. In the ﬁeld of neuropsychology, the tendency to
act upon acute impulses is referred to as disinhibition,
whereas in personality theories it is referred to as im-
pulsivity (Bachorowski & Newman, 1990; Zuckerman
et al. 1993). In the remainder of this paper, the term
disinhibition will be used to refer to both processes.
The second neurocognitive factor included in this
study as a predictor of relapse in PG is decision-
making under conﬂicting contingencies. A large body
of research indicates that in substance dependence
and in PG abnormalities exist in the ‘reward circuitry’
of the brain (e.g. Kambouropoulos & Staiger, 2001;
Martin-Soelch et al. 2001 ; Volkow et al. 2002b ; Reuter
et al. 2005), and in neurocognitive tasks tapping
into decision-making with conﬂicting reward and
punishment contingencies, in which short-term and
long-term rewards and punishments have to be
weighed (e.g. Monterosso et al. 2001 ; Bechara et al.
2002 ; Goudriaan et al. 2005). Speciﬁcally, neurobio-
logical studies indicate that diminished dopamine
receptor availability (due to substance dependence
or as a pre-existing vulnerability) causes a chronic
reward deﬁciency in the brain, resulting in a vulner-
ability to engaging excessively in rewarding behaviors
to normalize this deﬁcient state (Goldstein & Volkow,
2002; Volkow et al. 2002a). In neurocognitive studies
of decision-making, substance-dependent and PG
groups show a preference for immediate smaller
rewards at the expense of delayed bigger rewards, or
display behavioral strategies that lead to short-term
rewards but long-term losses (Monterosso et al.
2001 ; Bechara et al. 2002 ; Goudriaan et al. 2005). It
can be argued that the ‘reward deﬁciency syndrome’
will also result in a vulnerability to relapse, since
the reward deﬁciency will lead treated patients to
seek behaviors that normalize this deﬁcient state,
such as using drugs, or gambling (Volkow et al.
2002a). Empirical evidence for this argument comes
from a study that showed that diminished perform-
ance on a decision-making task that involves the
weighing of short-term rewards against long-term
losses, was related to relapse in a group of alcohol-
dependent patients (Bowden-Jones et al. 2005).
Another study indicated that lower dopamine recep-
tor responsivity after treatment for alcohol depen-
dence was a predictor for relapse (Markianos et al.
2001). Thus, both neurocognitive and neurobiological
indicators of decision-making and reward-processing
are predictors of relapse in alcohol dependence. In this
study, therefore, we focused on decision-making with
conﬂicting reward and punishment contingencies as
a second predictor of relapse in PG.
In the literature, a distinction is often made between
phenotypes (the disorder as it appears) and endo-
phenotypes (functions that underlie a disorder). In
general, self-report measures are viewed as indicators
of the phenotype of the disorder, whereas neurocogni-
tive, and neurobiological dispositions, are viewed
as endophenotypical indicators of the disorder. Other
examples of endophenotypical indicators are electro-
encephalogram measures of attentional bias (Waters
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et al. 2003), and the neuropharmacological eﬀects
on craving (Monti et al. 1999). Reviews suggest that
endophenotypes may have a stronger prognostic
value for the course of addictions and other mental
health problems than phenotypical indicators
(Gottesman & Gould, 2003 ; Ooteman et al. 2005). In
the current study, both endophenotypical (neuro-
cognitive : inhibition and decision-making under
conﬂicting contingencies) and phenotypical (self-
report measures on impulsivity and reward sensi-
tivity) concepts were studied.
In this naturalistic follow-up study, the presence
or absence of relapse was investigated in a PG group,
1 year after treatment. Logistic regression analysis
was performed, to investigate the predictive value of
self-reported and neurocognitive measures of inhi-
bition and decision-making on relapse in PG. Duration
of disorder was included as a third predictor, since
this factor has consistently been found to be associated
with relapse (Langenbucher et al. 1996 ; Simpson et al.
1999), and since a chronic course of the disorder
is likely to be related to the future course of the
disorder.
Method
Participants
The participants in this study were adult out-patient
pathological gamblers (n=46) who, at baseline, were
abstinent from gambling for less than 3 months.
Sample characteristics are displayed in Table 1. No
signiﬁcant diﬀerences in demographical data were
observed between the relapsed and non-relapsed
patients (age, p=0.18 ; gender, p=0.64 ; estimated IQ,
p=0.27). All of the pathological gamblers received an
intake in an out-patient addiction treatment center,
in Amsterdam, The Netherlands, and were enrolled
in cognitive behavioral treatment for pathological
gambling. The neurocognitive assessments were
made during the ﬁrst 2 weeks of cognitive behavioral
treatment. Of the 53 pathological gamblers tested,
46 were reached for the follow-up assessment (87%).
The seven participants who could not be traced did
not diﬀer from those who were retested in terms of
age, estimated IQ, and length of PG in years (two-
tailed Mann–Whitney U tests, signiﬁcance values
0.46, 0.87, and 0.18, respectively).
This paper is part of a larger study into neuro-
cognitive functions in PG, in comparison to normal
controls, alcohol dependents, and Tourette syndrome
patients. A paper regarding neurocognitive deﬁcits
in PG compared with these groups was published
elsewhere (Goudriaan et al. 2006). The current study
focused on follow-up data of the PG group.
Recruitment and screening methods
The participants were diagnosed according to DSM-IV
PG criteria, using the Dutch version of section T of
Table 1. Sample characteristics (n=46)
Relapsers Non-relapsers
Number of participants (female) 24 (4) 22 (5)
Age (S.D.) 40.0 (11.5) 36.3 (7.9)
Estimated full-scale IQa (S.D.) 115.9 (15.2) 119.8 (14.8)
Duration of PG in years (S.D.) 11.1 (9.2) 5.0 (4.4)
South Oaks Gambling Screen Score (S.D.) 12.32 (3.24) 10.20 (3.28)
Did you gamble again, after treatment? (n) Yes : 24 Yes : 7
No : 0 No: 15
Did you lose control over your gambling
behavior? (n)
Yes : 18 Yes : 0
No : 6 No: 7
Did you lose control less than/about
half/more than half of the time? (n)
More than half : 13 –
Less than half : 5 –
Do you think you have a gambling
problem again? (n)
Yes : 24 No: 7
Gambling problem: less severe/equally/
more severe (n)
Less severe : 5 –
Equally/more : 19 –
IQ, Intelligence quotient ; S.D., standard deviation ; PG, pathological gambling.
a The estimated IQ was based on two subtests of the Wechsler Adult Intelligence
Scale (Vocabulary and Block Design). These two subscale scores correlate in the 0.90s
with the full-scale WAIS score (Groth-Marnat, 1997).
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the DSM-IV Diagnostic Interview Schedule (Robins
et al. 1998). Co-morbid lifetime substance abuse or
dependence was diagnosed with section L of the
Composite International Diagnostic Interview (WHO,
1997). Since substance abuse and dependence could
inﬂuence neurocognitive functions, these conditions
were exclusion criteria in this study. Further exclusion
criteria were : (1) a history of major psychiatric dis-
orders (schizophrenia, psychotic episodes, bipolar
depressive disorder, and hospitalization for psychi-
atric disorders), (2) physical conditions known to
inﬂuence cognition or motor performance, and (3) the
use of psychotropic medication which could not
be discontinued.
Relapse
The PG treatment consisted of 10 sessions of 2 hours
including cognitive behavioral group therapy, focus-
ing on motivations for stopping gambling, strategy
development to cope with the urge to gamble, evalu-
ation of risk situations and coping strategies, and
explanation of randomness of chance. Relapse was
assessed through telephone interviews held approxi-
mately 1 year after baseline assessment (mean 14.2
months ; range 11–14 months). Four questions per-
taining to relapse into gambling were asked:
(1) After being treated for gambling problems, did
you gamble again? (Yes/No) ;
(2) Did you experience a loss of control over gam-
bling, when you engaged in gambling again? (Yes/
No).
When answering in the aﬃrmative, the person was
asked:
(3) whether this occurred: (a) only a few times, (b)
about half of the time they gambled, or (c) most
of the times they gambled;
(4) Do you think that you have a gambling problem
again? (Yes/No).
When answering in the aﬃrmative, the person was
questioned as to whether they experienced:
(a) a less severe gambling problem, (b) a similar
gambling problem, or (c) a more severe gam-
bling problem, compared with the time that
they sought help for their gambling problem.
Persons who answered ‘Yes’ to the question, ‘Do you
think that you have a gambling problem again?’
(question 4) were categorized as relapsers (n=24),
whereas those who indicated that they had no prob-
lems with gambling were categorized as non-relapsers
(n=22). Answers to these questions for the relapsed
and non-relapsed group are included in Table 1. These
data indicate that the division in the two groups
has high face validity, since the relapsers and the
non-relapsers diﬀered also in aspects such as loss of
control, and severity of subjectively experienced
gambling problems.
Neurocognitive measures
Means and standard errors of all predictors are
depicted in Table 2.
Disinhibition
The measurement of disinhibition consisted of two
tasks : Stop Signal Task and Stroop Color-Word task.
A measure of prepotent response inhibition, the
Stop Signal Reaction Time (SSRT) is derived from
the Stop Signal Task and described more elaborately
in Logan et al. (1984) and Scheres et al. (2001). Six
blocks of 64 trials were administered : the ﬁrst block
consisted of only Go trials ; subsequent blocks com-
prised both Go trials (75%) and Stop trials (25%). Go
trials required the subjects to perform a two-choice
reaction time task in which subjects had to react as
quickly as possible to an airplane appearing on the
screen by a right button press (airplane ﬂying to
the right) or a left button press (airplane to the left).
Stop trials were identical to Go trials but in addition
an auditory stop signal was presented requiring
subjects to inhibit their response. Stop signals were
presented using a tracking algorithm which ac-
complished 50% successful inhibition for each subject
by varying the delay between presentation of the
airplane and the stop signal. The dependent measure
was the SSRT, which measures the latency of the
inhibitory response. Higher SSRTs reﬂect worse in-
hibitory control (slower inhibitory processes).
A measure of interference control, the Stroop Color-
Word Task (Stroop, 1935; Hammes, 1971) consists of
three cards which are presented consecutively. On the
Table 2. Scores on neurocognitive and self-report measures of
disinhibition and decision-making under conﬂicting contingencies
Relapsers Non-relapsers
Stop Signal Reaction Time 149.55 (14.53) 121.7 (9.97)
Stroop Interference Score 33.96 (3.08) 29.50 (3.88)
Iowa Gambling Task
Advantageous Decks
(Cards 60–100)
20.48 (2.20) 22.15 (2.38)
Net score : Card Playing Task 8.22 (1.06) 11.40 (0.96)
BAS Reward Sensitivity Scale 17.64 (0.48) 17.25 (0.52)
Barrat Impulsivity Scale 56.64 (1.70) 54.05 (1.34)
BAS, Behavioral activation scale.
Values are mean (S.E.).
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ﬁrst card color words are printed in black. The subject
has to name the words as quickly as possible. The se-
cond card consists of colored rectangles, and the colors
have to be named. The last card consists of color words
which are printed in an ink color diﬀering from the
name of the color word. In this last condition, the
automatic process of reading has to be inhibited, and
the ink color in which the words are printed has to
be named. The dependent variable of this task was
the interference score : time in seconds needed to read
the third card minus time needed to read the second
card.
Decision-making under conﬂicting contingencies
Decision-making abilities were measured with two
tasks : The Iowa Gambling Task and the Card Playing
Task.
The total number of cards picked from the advan-
tageous decks during the last stages (last 40 cards),
of a computerized Iowa Gambling Task (IGT), was
taken as a measure of decision-making under con-
ﬂicting contingencies (Bechara et al. 1994). In the IGT,
subjects had to choose between four decks of cards.
Unbeknownst to the participant, two decks gave high
rewards, but also resulted in high losses, and were
disadvantageous in the long run. The other two piles
gave lower rewards, but also lower losses, and
resulted in a net gain in the long run. Respondents had
to discover which decks were advantageous in the
long run, and learn to select cards from the advan-
tageous decks instead of choosing the more risky,
disadvantageous decks.
The Card Playing Task was included as a measure
of perseveration for reward (Newman et al. 1987). In
this task, a stack of cards was displayed on a computer
screen. Number cards resulted in a loss of 50 euro-
cents. Face cards resulted in winning 50 eurocents.
Participants could choose to play a card (response
button 1) or choose to quit the task (response button 2).
The task consisted of 10 blocks of 10 cards. In each
block of cards, the ratio of wins to losses changed; the
number of cards increased with one loss card in each
block and decreased with one win card; in the ﬁrst
block the ratio of wins to losses was 9 to 1, in the
second block 8 to 2, and so on. The net result when
quitting the task was used as the dependent variable.
The measures of decision-making are described more
elaborately in Goudriaan et al. (2005).
Self-report measures
Disinhibition
A Dutch version of the Barratt Impulsiveness Scale-11
(Patton et al. 1995 ; Dutch version not published), of
this 30-item scale (4-choice Likert-type) consists of
three subscales : motor impulsiveness, attentional
impulsiveness, and non-planning impulsiveness.
Higher scores indicate higher disinhibition. Adequate
reliability has been established for the Barratt Im-
pulsivity Scale-11, with Cronbach’s a between 0.79
and 0.83 (Patton et al. 1995). For the purposes of this
study, the full-scale score was used (Cronbach’s
a=0.81, in the current study).
Reward sensitivity
The BIS/BAS self-report scale was administered
(Carver & White, 1994; Dutch version: Putman et al.
2004). This scale measures aﬀective responses to
impending rewards (BAS) or punishments (BIS) and
contains 20 items, scored on a 4-point Likert scale.
The BAS items are divided into three subcategories :
BAS drive, BAS reward sensitivity, and BAS fun-
seeking. The BAS reward sensitivity subscale (ﬁve
items) was used in this study, because our primary
research goal was to measure the inﬂuence of
decision-making with conﬂicting contingencies on
relapse, and the reward sensitivity subscale seemed
to approach this concept most closely. Higher
scores indicate higher reward sensitivity. Adequate
reliability for the BAS reward sensitivity subscale
(Cronbach’s a=0.74) was established in this study.
Estimated IQ
The estimated IQ was based on two subtests of the
Wechsler Adult Intelligence Scale (Vocabulary and
Block Design), which correlate >0.90 with the full-
scale IQ (Groth-Marnat, 1997). A minimum estimated
IQ of 80 was used as an inclusion criterion.
PG duration
The number of years of PG as reported in the
Diagnostic Interview Schedule was taken as an indi-
cation of PG duration.
Statistics
Logistic regression analysis was conducted to assess
the extent to which the predictor variables were re-
lated to relapse. In the multivariate logistic regression
model, duration of PG was entered ﬁrst. After that, the
self-report and neurocognitive measures were entered
in order to estimate the additive predictive value of
these measures on relapse. Eﬀect estimates with two-
tailed Wald-statistic p values were used. In the step-
wise regression, the p value to enter was set at 0.05,
and the p value to remove was set at 0.10 (Hosmer &
Lemeshow, 2000).
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To investigate whether multi-collinearity of the
neurocognitive and the self-report measures could
obscure the ﬁndings, correlations between these
predictors were studied. The only signiﬁcant corre-
lations that were found were those between the two
neurocognitive measures of disinhibition (r=0.36,
p<0.01) and between the two neurocognitive
decision-making measures (r=0.42, p<0.01). Multi-
collinearity diagnostic statistics for the logistic model
(tolerance values) were examined to exclude multi-
collinearity due to interdependency between the
neurocognitive predictor variables. High tolerance
values may signal problematic multi-collinearity,
which poses a threat to the validity of the logistic
regression model. Collinearity statistics yielded
tolerance values between 0.87 and 0.98, indicating
that the validity of the regression model was not
threatened by multi-collinearity. Therefore, the
neurocognitive measures were entered separately in
the logistic regression, instead of aggregating them
into a single score for ‘disinhibition’ or ‘decision-
making’.
Results
A test of the multivariate regression model with all
predictors against a constant-only model was sig-
niﬁcant. Duration of the disorder signiﬁcantly pre-
dicted relapse, x2 (1, n=46)=8.73, p<0.01. The
percentage explained variance with duration of PG
as the only predictor was 24% (Nagelkerke R2). In
the next step, the disinhibition (SSRT, Stroop Color-
Word Task) and decision-making (IGT, Card Playing
Task) variables, and the self-report measures (Barratt
Impulsivity Scale, and BAS-reward sensitivity sub-
scale) were entered. These variables added signiﬁ-
cantly to the prediction of relapse, x2 (6, n=46)=15.1,
p<0.05, and added 31% explained variance to the
model. The betas indicated that a longer duration of
PG, higher SSRT scores (indicating higher disinhi-
bition) and worse performance on the Card Playing
Task resulted in a higher likelihood of relapse.
The self-reported measures did not predict relapse
signiﬁcantly, nor did the Stroop interference
score, or IGT performance. The standardized beta-
coeﬃcients, Wald statistics and signiﬁcance levels for
the predictors included in the model are displayed in
Table 3. The percentage explained variance of the
full model was 55%. The overall classiﬁcation accu-
racy was 76%, with a positive predictive accuracy
of 76% (relapsers correctly classiﬁed in the relapse
group) and a negative predictive accuracy of 75%
(non-relapsers correctly classiﬁed in the non-relapse
group).
Discussion
This study is the ﬁrst that simultaneously examined
the inﬂuence of phenotypical and endophenotypical
measures of disinhibition and decision-making under
conﬂicting contingencies on relapse in PG. Results
from the current study indicated that two endo-
phenotypical measures of disinhibition and abnormal
decision-making under conﬂicting contingencies were
predictive of relapse in PG, whereas phenotypical
(self-report) measures did not predict relapse.
Our ﬁnding, that decision-making abilities were
predictive of relapse, is consistent with a study using
the same Card Playing task in adolescents, which
found that diminished performance on this task
(lower net scores) was related to the development
of PG (Vitaro et al. 1999). Thus, disadvantageous
decision-making strategies in the Card Playing Task
seem to be a vulnerability factor involved in develop-
ment as well as in relapse of PG. The ﬁnding that
neurocognitive disinhibition is predictive of relapse
is consistent with studies indicating that impairments
in self-regulatory neurocognitive functions inﬂuence
relapse in substance dependence (Tapert et al. 1999;
Allsop et al. 2000 ; Bowden-Jones et al. 2005). Not all
of the neurocognitive variables predicted relapse : a
measure of prepotent response inhibition predicted
relapse, whereas the Stroop Interference score did
not. Likewise, the Card Playing Task was a signiﬁcant
predictor, whereas performance on the IGT was
not. This may be explained by the complexity of the
factors that are tested in the tasks that did not predict
Table 3. Multivariate prediction of relapse in pathological
gambling (PG) with a logistic regression model
Predictorsa Beta S.E.
Wald
statistic
p
value
Duration PG (years) 2.50 0.98 6.81 0.01
Stop Signal Reaction
Time
1.11 0.53 4.34 0.03
Stroop Interference
Score
0.58 0.42 1.88 0.17
Iowa Gambling Task
Net Result
0.39 0.45 0.72 0.39
Card Playing Task Net
Result
x1.53 0.63 5.83 0.02
Baratt Impulsivity
Scale
0.63 0.49 1.61 0.20
BAS Reward
Sensitivity Scale
0.28 0.49 0.33 0.57
BAS, Behavioral activation scale.
a All predictors were converted to z scores, to allow for
comparison of the beta values.
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relapse. In the Stroop Color-Word Task, inhibiting
an automatic response while reading is required,
but only simple inhibition of a motor response in the
Stop Signal Task is necessary. The four-deck IGT is a
complex task in which several cognitive and motiv-
ational processes inﬂuence performance, such as
memory and contingency learning (Busemeyer &
Stout, 2002), whereas the choice to play or quit on the
one-deck Card Playing Task, is much simpler. Thus,
the more simple tasks may have tapped certain aspects
of executive functions more clearly, whereas the mix
of cognitive demands in the more complex tasks may
have diluted the predicting power of an aspect such as
‘disinhibition’. However, larger samples are needed
to detect diﬀerential predictive power of neurocogni-
tive tasks tapping self-regulatory functions.
In this study, all predictors together explained 55%
of the variance of relapse. The variance not accounted
for could be lowered in future studies by the inclusion
of factors such as treatment adherence, recent life
events precipitating relapse, and co-morbid psycho-
pathology. It is likely that these factors independently
explain some variance in relapse (Gottlieb et al. 1994 ;
Bottlender & Soyka, 2005). Bates and colleagues (2002)
argued that the inﬂuence of neurocognitive impair-
ment on relapse in substance dependence can be both
direct and indirect, with neurocognitive impairment
interacting with other intrapersonal and interpersonal
capabilities and contextual factors. For instance,
diminished neurocognitive functioning could lead
to a diminished ability to implement coping skills
when confronted with situations which create the
urge to gamble (Tapert et al. 1999). Living close to a
gambling establishment in combination with being
disinhibited could lead to a diminished ability to
inhibit the urge to enter a gambling establishment.
Studies on relapse in patients with substance use dis-
orders indeed indicate that neurocognitive abilities
interact with intrapersonal and environmental factors
in the prediction of relapse (Tapert et al. 1999 ; Latimer
et al. 2000 ; Bauer, 2001 ; Bates et al. 2004). Therefore,
it is likely that interactions between neurocognitive
deﬁcits and factors such as coping skills, gambling
behavior of relatives and friends, and proximity to
gambling opportunities inﬂuence relapse in PG in a
similar way. Data on these factors were not available
in our study, and future research should address these
issues.
Our ﬁnding that neurocognitive factors predict
relapse in PG is also important from an etiological
point of view. Neurocognitive dysfunctions, and
more particularly diminished executive functions
and disadvantageous decision-making skills in tasks
including rewards and losses, are likely to be im-
portant endophenotypic markers, inﬂuencing the
development of both chemical and non-chemical ad-
dictions (Blum et al. 2000 ; Goldstein & Volkow, 2002).
Recently, neurocognitive disinhibition was found to
be associated with the development of substance use
disorders as well (Tarter et al. 2004). Thus, similar
neurocognitive etiologies may be involved in the
development as well as the progression of and relapse
in PG and substance dependence (Tapert et al. 1999;
Allsop et al. 2000).
Self-reported personality variables of disinhibition
or reward sensitivity did not predict relapse in PG.
The only other study on the role of personality factors
on relapse in PG showed negative results, except for
a trend for sensation-seeking (Blaszczynski et al.
1991). Similarly, phenotypic indicators of treatment
success in alcohol dependence also generate incon-
sistent results (Ooteman et al. 2005). Neurocognitive
functioning has been reported as an endophenotypical
marker in developmental models of alcohol and drug
dependence (Deckel et al. 1995 ; Giancola & Moss,
1998 ; Hesselbrock et al. 2001 ; Tarter et al. 2004). It is
argued that research on endophenotypes may clarify
the classiﬁcation and diagnosis of complex psychiatric
disorders – such as PG – and may ultimately provide
a link between genotypes and phenotypes of these
disorders (Gottesman &Gould, 2003). Our ﬁnding that
only neurocognitive measures of disinhibition and
decision-making were predictive of relapse suggests
that future research on the course of pathological
gambling and related disorders will beneﬁt more
from the inclusion of endophenotypic indicators, such
as neuropsychological, neurophysiological, neuro-
imaging, and biochemical functions than from self-
report personality measures.
We did not study whether performance on the
neurocognitive tasks also was predictive of treatment
success. Studies in alcohol dependence indicate that
there is a relation between neurocognitive function
and treatment adherence in alcohol-dependent
patients (for a review see Bates et al. 2002). Future
research could shed light on the question of whether
a similar relation would be revealed in pathological
gamblers.
Some limitations of this study should be noted.
The sample size was rather small, which limited the
number of predictors that could be studied, in order to
diminish the possibility of type II errors. The above-
mentioned intrapersonal factors such as coping skills,
and environmental factors such as gambling in rela-
tives and friends, should be implemented in future
studies, in order to extend the ﬁndings of this study.
The limitation of this study to an out-patient PG
group without other substance dependence or major
psychiatric diagnoses increases the internal validity of
this study, but restricts generalization of the ﬁndings
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to this particular group. It is likely that the presence
of substance dependence or other psychiatric co-
morbidity will result in a higher chance of relapse. In
subgroups of PG with serious psychopathology these
factors may have a stronger eﬀect on relapse than
neurocognitive functions per se. With the current
sample, this question could not be answered, and
future relapse studies should address this issue.
Assessing duration of PG and neurocognitive
functions in pathological gamblers seems a valuable
addition to assessing the risk of relapse in PG. Scores
on neurocognitive functions could be used as indi-
cators for the need for extra interventions, such as
assignment to more intense treatment programs
that include learning strategies to cope with dimin-
ished inhibition and disadvantageous decision-
making strategies, or the implementation of booster
sessions in the post-treatment period. In a review on
eﬀects of diminished neurocognitive functions on
treatment in alcohol dependence, it is argued that
diminished planning abilities and higher impulsivity
could result in lower treatment compliance and re-
tention (Bates et al. 2002). Diminished neurocognitive
functioning in PG may also lead to lower eﬀectiveness
of treatment interventions. Structuring treatment
interventions, promoting treatment adherence, and
helping pathological gamblers in identifying personal
risk situations may therefore improve the eﬀect of
treatment interventions in persons with neurocogni-
tive impairments. Thus, the assessment of neuro-
cognitive functions may be useful not only for
identifying and targeting pathological gamblers at risk
for relapse, but may also help in improving the eﬀect
of treatment in those with neurocognitive deﬁcits.
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